Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 347903, 9 pages
http://dx.doi.org/10.1155/2015/347903
Research Article

Effective Binding of a Phosphatidylserine-Targeting Antibody to Ebola Virus Infected Cells and Purified Virions

1Public Health England, Porton Down, Wiltshire, Salisbury SP4 0JG, UK
2Peregrine Pharmaceuticals, Inc., Tustin, CA 92780, USA

Received 25 February 2014; Revised 20 June 2014; Accepted 3 September 2014

Academic Editor: Caroline Rowland

Copyright © 2015 S. D. Dowall et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. J. Adams and E. B. Carstens, “Ratification vote on taxonomic proposals to the international committee on taxonomy of viruses (2012),” Archives of Virology, vol. 157, no. 7, pp. 1411–1422, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. J. H. Kuhn, S. Becker, H. Ebihara et al., “Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations,” Archives of Virology, vol. 155, no. 12, pp. 2083–2103, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. WHO, “Ebola haemorrhagic fever in Zaire, 1976: report of an international commission,” Bulletin of the World Health Organization, vol. 56, no. 2, pp. 271–293, 1978. View at Google Scholar · View at Scopus
  4. E. M. Leroy, J.-P. Gonzalez, and S. Baize, “Ebola and Marburg haemorrhagic fever viruses: Major scientific advances, but a relatively minor public health threat for Africa,” Clinical Microbiology and Infection, vol. 17, no. 7, pp. 964–976, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. N. D. Wolfe, A. T. Prosser, J. K. Carr et al., “Exposure to nonhuman primates in rural Cameroon,” Emerging Infectious Diseases, vol. 10, no. 12, pp. 2094–2099, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Borio, T. Inglesby, C. J. Peters et al., “Hemorrhagic fever viruses as biological weapons: medical and public health management,” The Journal of the American Medical Association, vol. 287, no. 18, pp. 2391–2405, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. T. W. Geisbert, A. C. Lee, M. Robbins et al., “Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study,” The Lancet, vol. 375, no. 9729, pp. 1896–1905, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. T. K. Warren, K. L. Warfield, J. Wells et al., “Advanced antisense therapies for postexposure protection against lethal filovirus infections,” Nature Medicine, vol. 16, no. 9, pp. 991–994, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. J. M. Dye, A. S. Herbert, A. I. Kuehne et al., “Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 13, pp. 5034–5039, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. G. G. Olinger Jr., J. Pettitt, D. Kim et al., “Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 44, pp. 18030–18035, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Qiu, J. Audet, G. Wong et al., “Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies,” Science Translational Medicine, vol. 4, no. 138, Article ID 138ra81, 2012. View at Publisher · View at Google Scholar
  12. S. Ran, J. He, X. Huang, M. Soares, D. Scothorn, and P. E. Thorpe, “Antitumor effects of a monoclonal antibody that binds anionic phospholipids on the surface of tumor blood vessels in mice,” Clinical Cancer Research, vol. 11, no. 4, pp. 1551–1562, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. P. E. Thorpe, “Targeting anionic phospholipids on tumor blood vessels and tumor cells,” Thrombosis Research, vol. 125, supplement 2, pp. S134–S137, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Schutters and C. Reutelingsperger, “Phosphatidylserine targeting for diagnosis and treatment of human diseases,” Apoptosis, vol. 15, no. 9, pp. 1072–1082, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. M. O. Hengartner, “The biochemistry of apoptosis,” Nature, vol. 407, no. 6805, pp. 770–776, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Kobayashi, P. Karisola, V. Peña-Cruz et al., “TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells,” Immunity, vol. 27, no. 6, pp. 927–940, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. S. J. Martin, D. M. Finucane, G. P. Amarante-Mendes, G. A. O'Brien, and D. R. Green, “Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity,” The Journal of Biological Chemistry, vol. 271, no. 46, pp. 28753–28756, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. X. Huang, M. Bennett, and P. E. Thorpe, “A monoclonal antibody that binds anionic phospholipids on tumor blood vessels enhances the antitumor effect of docetaxel on human breast tumors in mice,” Cancer Research, vol. 65, no. 10, pp. 4408–4416, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. T. A. Luster, J. He, X. Huang et al., “Plasma protein β-2-glycoprotein 1 mediates interaction between the anti-tumor monoclonal antibody 3G4 and anionic phospholipids on endothelial cells,” The Journal of Biological Chemistry, vol. 281, no. 40, pp. 29863–29871, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. D. E. Gerber, A. T. Stopeck, L. Wong et al., “Phase I safety and pharmacokinetic study of bavituximab, a chimeric phosphatidylserine-targeting monoclonal antibody, in patients with advanced solid tumors,” Clinical Cancer Research, vol. 17, no. 21, pp. 6888–6896, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. J. M. Reichert, “Antibodies to watch in 2014: mid-year update,” MAbs, vol. 6, no. 4, pp. 799–802, 2014. View at Publisher · View at Google Scholar
  22. J. C. Pai, J. N. Sutherland, and J. A. Maynard, “Progress towards recombinant anti-infective antibodies,” Recent Patents on Anti-Infective Drug Discovery, vol. 4, no. 1, pp. 1–17, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. M. M. Soares, S. W. King, and P. E. Thorpe, “Targeting inside-out phosphatidylserine as a therapeutic strategy for viral diseases,” Nature Medicine, vol. 14, no. 12, pp. 1357–1362, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. H. M. Mir, A. Birerdinc, and Z. M. Younossi, “Monoclonal and polyclonal antibodies against the HCV envelope proteins,” Clinics in Liver Disease, vol. 13, no. 3, pp. 477–486, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Sakamoto and M. Watanabe, “New therapeutic approaches to hepatitis C virus,” Journal of Gastroenterology, vol. 44, no. 7, pp. 643–649, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Tomillero and M. A. Moral, “Gateways to clinical trials,” Methods and Findings in Experimental and Clinical Pharmacology, vol. 30, no. 8, pp. 643–672, 2008. View at Google Scholar · View at Scopus
  27. A. Tomillero and M. A. Moral, “Gateways to clinical trials,” Methods and Findings in Experimental and Clinical Pharmacology, vol. 30, no. 7, pp. 543–588, 2008. View at Google Scholar
  28. P. B. Jahrling, R. A. Hesse, J. B. Rhoderick, M. A. Elwell, and J. B. Moe, “Pathogenesis of a pichinde virus strain adapted to produce lethal infections in guinea pigs,” Infection and Immunity, vol. 32, no. 2, pp. 872–880, 1981. View at Google Scholar · View at Scopus
  29. E. T. Bowen, G. Lloyd, W. J. Harris, G. S. Platt, A. Baskerville, and E. E. Vella, “Viral haemorrhagic fever in southern Sudan and northern Zaire. Preliminary studies on the aetiological agent,” The Lancet, vol. 1, no. 8011, pp. 571–573, 1977. View at Google Scholar · View at Scopus
  30. K. M. Johnson, P. A. Webb, J. V. Lange, and F. A. Murphy, “Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire,” The Lancet, vol. I, no. 8011, pp. 569–571, 1977. View at Google Scholar · View at Scopus
  31. S. Pattyn, W. Jacob, and G. van der Groen, “Isolation of Marburg like virus from a case of haemorrhagic fever in Zaire,” The Lancet, vol. 1, no. 8011, pp. 573–574, 1977. View at Google Scholar · View at Scopus
  32. L. J. Reed and H. Muench, “A simple method of estimating fifty per cent endpoints,” The American Journal of Epidemiology, vol. 27, no. 3, pp. 493–497, 1938. View at Google Scholar · View at Scopus
  33. W. Bou-Assaly and S. Mukherji, “Cetuximab (erbitux),” American Journal of Neuroradiology, vol. 31, no. 4, pp. 626–627, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. D. A. Coil and A. D. Miller, “Enhancement of enveloped virus entry by phosphatidylserine,” Journal of Virology, vol. 79, no. 17, pp. 11496–11500, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Mercer and A. Helenius, “Apoptotic mimicry: phosphatidylserine-mediated macropinocytosis of vaccinia virus,” Annals of the New York Academy of Sciences, vol. 1209, no. 1, pp. 49–55, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Vanlandschoot and G. Leroux-Roels, “Viral apoptotic mimicry: an immune evasion strategy developed by the hepatitis B virus?” Trends in Immunology, vol. 24, no. 3, pp. 144–147, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. M. K. Callahan, P. M. Popernack, S. Tsutsui, L. Truong, R. A. Schlegel, and A. J. Henderson, “Phosphatidylserine on HIV envelope is a cofactor for infection of monocytic cells,” Journal of Immunology, vol. 170, no. 9, pp. 4840–4845, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. J. A. G. Briggs, T. Wilk, and S. D. Fuller, “Do lipid rafts mediate virus assembly and pseudotyping?” Journal of General Virology, vol. 84, part 4, pp. 757–768, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Bavari, C. M. Bosio, E. Wiegand et al., “Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses,” Journal of Experimental Medicine, vol. 195, no. 5, pp. 593–602, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. L. J. Pike, X. Han, K.-N. Chung, and R. W. Gross, “Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis,” Biochemistry, vol. 41, no. 6, pp. 2075–2088, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Ishii, T. Mori, A. Shiratsuchi et al., “Distinct localization of lipid rafts and externalized phosphatidylserine at the surface of apoptotic cells,” Biochemical and Biophysical Research Communications, vol. 327, no. 1, pp. 94–99, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Ono and E. O. Freed, “Plasma membrane rafts play a critical role in HIV-1 assembly and release,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 24, pp. 13925–13930, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. P. Scheiffele, A. Rietveld, T. Wilk, and K. Simons, “Influenza viruses select ordered lipid domains during budding from the plasma membrane,” Journal of Biological Chemistry, vol. 274, no. 4, pp. 2038–2044, 1999. View at Publisher · View at Google Scholar · View at Scopus
  44. W. F. Pickl, F. X. Pimentel-Muiñios, and B. Seed, “Lipid rafts and pseudotyping,” Journal of Virology, vol. 75, no. 15, pp. 7175–7183, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. G. Brown, H. W. M. Rixon, and R. J. Sugrue, “Respiratory syncytial virus assembly occurs in GM1-rich regions of the host-cell membrane and alters the cellular distribution of tyrosine phosphorylated caveolin-1,” Journal of General Virology, vol. 83, part 8, pp. 1841–1850, 2002. View at Google Scholar · View at Scopus
  46. P. Aleksandrowicz, A. Marzi, N. Biedenkopf et al., “Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis,” Journal of Infectious Diseases, vol. 204, supplement 3, pp. S957–S967, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Nanbo, M. Imai, S. Watanabe et al., “Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner,” PLoS Pathogens, vol. 6, no. 9, Article ID e01121, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. M. F. Saeed, A. A. Kolokoltsov, T. Albrecht, and R. A. Davey, “Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes,” PLoS Pathogens, vol. 6, no. 9, Article ID e01110, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Mourdjeva, D. Kyurkchiev, A. Mandinova, I. Altankova, I. Kehayov, and S. Kyurkchiev, “Dynamics of membrane translocation of phosphatidylserine during apoptosis detected by a monoclonal antibody,” Apoptosis, vol. 10, no. 1, pp. 209–217, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. O. Martinez, L. W. Leung, and C. F. Basler, “The role of antigen-presenting cells in filoviral hemorrhagic fever: gaps in current knowledge,” Antiviral Research, vol. 93, no. 3, pp. 416–428, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Takada, “Filovirus tropism: cellular molecules for viral entry,” Frontiers in Microbiology, vol. 3, article 34, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Lehner, “Monoclonal antibodies against micro-organisms,” Current Opinion in Immunology, vol. 1, no. 3, pp. 462–466, 1988. View at Google Scholar · View at Scopus
  53. L. G. Presta, “Molecular engineering and design of therapeutic antibodies,” Current Opinion in Immunology, vol. 20, no. 4, pp. 460–470, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. N. Fernández, M. Renedo, C. García-Rodríguez, and M. Sánchez Crespo, “Activation of monocytic cells through Fcγ receptors induces the expression of macrophage-inflammatory protein (MIP)-1α, MIP-1β and RANTES,” The Journal of Immunology, vol. 169, no. 6, pp. 3321–3328, 2002. View at Publisher · View at Google Scholar · View at Scopus
  55. D. N. Forthal, G. Landucci, T. B. Phan, and J. Becerra, “Interactions between natural killer cells and antibody Fc result in enhanced antibody neutralization of human immunodeficiency virus type 1,” Journal of Virology, vol. 79, no. 4, pp. 2042–2049, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. T. R. D. J. Radstake, R. van der Voort, M. Ten Brummelhuis et al., “Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis, and regulation by Fc gamma receptors,” Annals of the Rheumatic Diseases, vol. 64, no. 3, pp. 359–367, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. X. Huang, D. Ye, and P. E. Thorpe, “Enhancing the potency of a whole-cell breast cancer vaccine in mice with an antibody-IL-2 immunocytokine that targets exposed phosphatidylserine,” Vaccine, vol. 29, no. 29-30, pp. 4785–4793, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. D. E. Milenic, E. D. Brady, and M. W. Brechbiel, “Antibody-targeted radiation cancer therapy,” Nature Reviews Drug Discovery, vol. 3, no. 6, pp. 488–499, 2004. View at Publisher · View at Google Scholar · View at Scopus